Zevra Therapeutics ZVRA
NASDAQ ZVRA
$9.99 -0.19 (-1.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Accumulated Expenses (2014 - 2021)

Updated

Zevra Therapeutics' Accumulated Expenses came in at $700,000 for Q4 2021, unchanged from $700,000 a year earlier.

Analysis

Zevra Therapeutics (ZVRA) Accumulated Expenses (2014 - 2021) Analysis & Trends

Going back to Q4 2014, Zevra Therapeutics' Accumulated Expenses data covers 8 quarters.

  • Accumulated Expenses carries a five-year compound annual growth rate of 0.0% (FY2016 to FY2021).
  • Going back by year, Accumulated Expenses was $700,000 in FY2020 (unchanged), $700,000 in FY2019 (unchanged), $700,000 in FY2018 (unchanged) and $700,000 in FY2017 (unchanged).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Zevra Therapeutics 604.10 Mn -208.61 Mn 38.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 700,000.00
Dec 31, 2020 700,000.00
Dec 31, 2019 700,000.00
Dec 31, 2018 700,000.00
Dec 31, 2017 700,000.00
Dec 31, 2016 700,000.00
Dec 31, 2015 700,000.00
Dec 31, 2014 700,000.00
API Access

Zevra Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY